Manufacturer
Novo Nordisk Pharma
Pharmaceutical manufacturer based in Denmark
Denmark
- Products listed
- 4
- Molecules
- 2
- Therapy areas
- 1
Novo Nordisk Pharma is a pharmaceutical manufacturer based in Denmark. MedsAcross lists 4 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Denmark
- Indian manufacturer
- No
- Also listed as
- Novo Nordisk Pharma, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Novo Nordisk Pharma products through licensed channels, with the documents your regulator needs.
Diabetes
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Insulin aspart 100 IU/mL injectionIntravenous, subcutaneous Cold chainGeneric name | Insulin aspart | US FDA | Available on request |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30 100 IU/mL injectable suspensionSubcutaneous Cold chain | Insulin aspart | US FDA | Available on request |
| Insulin degludec 100 units/mL injectionSubcutaneous Cold chainGeneric name | Insulin degludec | US FDA | Available on request |
| Insulin degludec 200 units/mL injectionSubcutaneous Cold chainGeneric name | Insulin degludec | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Novo Nordisk Pharma
Send a request for any of these products. We confirm the licensed source, documents and lead time.